An Open-Label, Single-Dose, Randomized, Four-Way Crossover Study In Healthy Volunteers To Evaluate The Effects Of Caloric Content And Time Of Dosing On The Pharmacokinetics Of Pregabalin Controlled Release Formulation As Compared To The Immediate Release Formulation.
Latest Information Update: 25 Jan 2021
At a glance
- Drugs Pregabalin (Primary) ; Pregabalin
- Indications Fibromyalgia; Generalised anxiety disorder; Neuropathic pain; Partial epilepsies; Postherpetic neuralgia; Tonic-clonic epilepsy
- Focus Pharmacokinetics
- Sponsors Pfizer
Most Recent Events
- 13 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Feb 2011 New trial record